跳至主要内容
临床试验/KCT0009499
KCT0009499已完成Unknown

Clinical trial for Comparative Study on the effect of oral intake of LB-P9 on maintaining hair health(Random Allocation, Double Blindness, Control Comparison)

ISCure Biosciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1) Men and women aged 18 to 60 with mild or more damaged hair without healthy hair loss disease
  • - Adult men and women with a gloss score of 1 to 3 according to the visual evaluation classification method, and a total score of hair damage assessed according to exposure to risk factors, less than 18.
  • 2) Subjects who will not engage in any special hair products or hair care and manipulation during the study period
  • 3) Those who have agreed to maintain the same hair shape, color and length during the study period
  • - Those whose hair length is 8cm or more when measured from the top of the head
  • 4) A person who voluntarily agrees to participate and signs a written consent form before the start of this human body application test

排除标准

  • 1) Severe acute kidney or heart disease that could affect the results of the trial in the last six months
  • 2) Patients with hypertension who are not controlled during screening (blood pressure 180/110mmHg or higher; however, those who are stably controlling blood pressure with drug treatment can participate)
  • 3) Diabetes patients who are not controlled during screening (HbA1c 9% or more)
  • 4) Patients with uncontrolled hyperthyroidism or hypothyroidism at screening time
  • 5) In clinical laboratory examination results during screening, creatinine concentration is more than twice the upper limit of the research institute, or patients with chronic renal failure or kidney disease requiring dialysis
  • 6) At screening, clinical laboratory examination results show that AST or ALT concentrations are more than twice the normal upper limit of the research institute, or drug/alcoholic hepatitis, cirrhosis, fatty liver patients requiring treatment
  • 7) a person who complains of severe gastrointestinal symptoms
  • 8) A person with a history of malignant tumors within the past 5 years
  • 9) a person with a psychiatric condition
  • 10) A person with an infectious skin disease
  • 11) Patients with other hair loss diseases such as androgenic alopecia, atypical alopecia, resting alopecia, and scarring alopecia
  • 12) A person who is pregnant, lactating, or planning to become pregnant
  • 13) Those who have taken oral Dutasteride or Finasteride in the last 6 months
  • 14) Those who have been applying local hair growth agents, wool, and hair growth agents for the past month
  • 15) Those who have taken the following drugs in the last 1 month: Steroids, apoptosis, vasodilators, antihypertension, anti-interstitial drugs, beta receptor blockers, bronchodilators, diuretics, Cimetidine, Diazoxide, Cyclosporine, Ketoconazole
  • 16) Those who have been applying topical steroids to their scalp for the past month
  • 17) Those who have been taking lactobacilli preparations within the last month
  • 18) A person who has taken drugs that may affect hair growth within three months or is currently taking them
  • 19) A person who has consumed functional health food recognized by the Ministry of Food and Drug Safety within three months prior to the start of the test
  • 20) A person who participated in other human application tests and clinical trials within three months prior to the start of this human application test
  • 21) A person whose alcohol intake falls under the following (men's 40g/day or more, women's 20g/day or more, alcohol 40g=17 degree soju 0.8 bottles or 1L of beer)
  • 22) Those who are allergic or have side effects to test foods
  • 23) A person who is deemed unsuitable for the examination by the examiner for other reasons

研究者

发起方
ISCure Biosciences

相似试验